BEENISH S. BHUTTA
315
CENTRALLT ACTING
SYMPATHOPLEGICS
 MOA
REDUCE SYMPATHETIC OUTFLOW
FROM VASOMOTOR CENTER BUT
RETAIN OR EVEN INC SENSITIVITY
TO BARORECEPTOR CONTROL
Actions less dependent on posture
METHLY DOPA
 α METHYLDOPAMINE
 α METHYLNOREPINEPHERINE
 ACT ON CENTRAL α
ADRENOCEPTORS
ACTIONS
 REDUCE PERIPHERAL
VASCULAR RRESISTANCE
 VARIABLE RED IN CARDIAC OUTPUT
AND HEART RATE
 DOA: 12-24HR
TOXICITY
 Postural hypotension in vol. depleted pts
 Sedation------at onset
 LONG TERM USE-----persistent mental
lassitude, impaired mental
conc., nightmares, mental depression, extra-
pyramidal signs
 LACTATION—men & women.. Inhib of
dopaminergic mech. in hypothalamus
 POSITIVE COOMBS TEST---hemolytic
anemia , hepatitis & drug fever
 Discont.-----PROMPT REVERS OF
ABNORMALITIES
DRUG INTERACTIONS
 NSAIDS
 SYSTEMIC CORTICOSTEROIDS
CLONIDINE
 α ADRENOCEPTORS IN
MEDULLA OF BRAIN---Sensitizes
vasomotor centers to Inhib by
baroreflexes
 RED. SYMPATHETIC AND INC.
PARASYMPATHETIC TONE
 Nonadrenoceptor site----IMIDAZOLE
RECEPTOR
ACTIONS
 I/V---BRIEF INC IN BLOOD
PRESSURE( PARTIAL α AGONIST)
followed by MORE PROLONGED
HYPOTENTION
 DEC. CARDIAC RATE AND C.O
 RELAXATION OF CAPACITANCE
VESSELS---DEC IN PVR
TOXICITY
 SEDATION
 DRY MOUTH
 MENTAL DEPRESSION----WITHDRAW
 WITHDRAWAL AFTER PROTRACTED
USE:
LIFE THREATENING HYPOTENSIVE
CRISIS
 Nervousness, tachycardia, headache &
sweating---omitting 1 or 2 doses of drug
DRUG INTERACTIONS
 TCA MAY BLOCK THE ANTI
HYPOTENSIVE EFFECT
 NSAIDS MAY ENHANCE THE
ANTIPOTENSIVE EFFECT
OTHERS..
GUANABENZ
GUANFACINE
RARELY USED….
GANGLION BLOCKING
AGENTS
 MOA
 COMPETITIVELY BLOCK NICOTINIC
CHOLINOCEPTORS ON POST
GANGLIONIC NEURONS IN
BOTH SYMPATHETIC &
PARASYMPATHETIC OUTFLOW
 MAY DIRECTLY BLOCK
NICOTINIC Ach channel
TO NAME A FEW..
HEXAMETHONIUM
MECAMYALINE
TRIMETHAPHAN
ADVERSE EFFECTS
 SYMPATHOPLEGIA: excessive
orthostatic hypotension & sexual
dysfunction
 PARASYMPATHOPLEGIA:
constipation, blurred
vision, precipitation of glaucoma, dry
mouth, urinary retention
ADRENERGIC NEURON
BLOCKING AGENTS
 MOA
PREVENT NORMAL PHYSIOLOGICAL
RELEASE OF NOREPINEPHRINE
FROM POST GANGLIONIC
SYMPATHETIC NEURONS
GUANITHIDINE
 MOA---transported across symp nerve
ending by NET, conc. In vesicles, NE
replaced….gradual depletion of NE
TOXICITY
 SYMPTOMATIC POSTURAL
HYPOTENTION OR AFTER EXERCISE
 DIARREHA
 DELAYED OR RETROGRADE
EJACULATION
CONTRA-INDICATIONS
 SYMPATHOMIMETIC AGENTS—cause
HYPERTENSION
 CAN PRODUCE HYPERTENSIVE
CRISIS BY RELEASING
CHATECHOLAMINES IN PTS WITH
PHEOCHROMOCYTOMA
 TCA ATTENUATE
ANTIHYPERTENSIVE EFFECT---
SEVERE HYPERTENSION
THESE BLOCK NEURONAL
UPTAKE OR DISPLACE
AMINES FROM NERVE
TERMINALS
 COCAINE
 AMPHETAMINE
 TCA
 PHENOTHIAZINES
 PHENOXYBENZAMINE
RESERPINE
 MOA
 Blocks the ability of aminergic
transmitter vesicles to take up and store
biological amines----interfere VMAT
 -> DEPLETION OF
NE, DOPAMINE & SEROTININ
BOTH IN CENTRAL AND PERIPHERAL
NERVOUS SYSTEM
 CROMAFFIN GRANULES OF AD.
MEDULLA ARE ALSO DEPLETED
TOXICITY
 LOW DOSES—LITTLE POSTURAL
HYPOTENSION
 HIGH DOSES–
SEDATION, LASSITUDE, NIGHTMARE
S, SEVERE MENTAL DEPRESSION—
occasionally with low doses too
 EXTRAPYRAMIDAL EFFECTS due to low
dopamine in CS.
 GIT MILD DIARREHA, GIT
CRAMPS, INCREASED GASTRIC ACID
SECRETION
 CONTRAINDICATED WITH H/O
PEPTIC ULCER
β- ADRENOCEPTOR
BLOCKERS
PROPRANOLOL
 MOA
 NONSELECTIVE β- BLOCKADE
 PRIMARILY DECREASE IN CARDIAC OUTPUT
 INHIBITS STIMULATION OF RENIN
PRODUCTION BY
CATECHOLAMINES( β1)
 ACTS ON PERIPHERAL PRESYNAPTIC β-
ADRENOCEPTORS TO REDUCE
SYMPATHETIC VASOCONSTRICTIVE
ACTIVITY
 IN MILD TO MODERATE HYPERTENSION
SIGNIFICANT REDUCTION IB B.P WITHOUT
PROMINENT POSTURAL HYPOTENSION
TOXICITY
 BRADYCHARDIA
 WORSONED ASTHAMA
 FATIGUE
 VIVID DREAMS
 COLD HANDS
 DISCONTINUATION AFTER
PROLONGED REGULAR USE
WITHDRAWAL SYNDROME:
nervousness, tachycardia, increased
intensity of angina, increased B.P
OTHERS
 METOPROLOL & ATENOLOL
 GREATER SELECTIVITY TO β1-
ADRENOCEPTERS
 INDICATIONS:
HYPERTENSION, ARRYTHMIAS, ANGIN
A, EARLY MANAGEMENT OF MI
 Metoprolol thyrotoxicosis &
migraine prophylaxis
 NADOLOL & CARTEOLOL:
NONSELECTIVE β - RECPTOR
ANTAGONISTS, REDUCED
DOSES IN RENAL DISEASE
 BETAXOLOL &
BISOPROLOL:β1 BLOCKER
PINDOLOL, ACEBUTOLOL, P
ENBUTOLOL
 PARTIAL AGONISTS: β- BLOCKERS
WITH SOME INTRINSIC
SYMPATHOMIMETIC ACTIVITY
 REDUCE VASCULAR
RESISTANCE
 REDUCE CARDIAC OUTPUT OR
H.R LESS THAN OTHERS due to
agonist activity beneficial in cases of
bradyarrhythmias or PVD
LABETOLO, CARVEDILOL, NE
BIVOLOL
 β- BLOCKING AND VASODILATING
ACTIVITY
 LABETOLOL: 4 ISOMERS; 3:1 RATIO
OF β:α BLOCKADE
REDUCED SYSTEMIC VASCULAR
RESISTANCE(α-
BLOCKADE), COMBINED ACTIVITY
PHEOCROMOCYTOMA &
HYPERTENSIVE EMERGENCIES
CONT..
 CARVEDILOL: HEART FAILURE
AND HYPERTENSION
 NEBIVOLOL:
 D- ISOMER: β-1 SELECTIVE
 L-ISOMER: NITRIC OXIDE
SYNTHASE INDUCER PVR is
acutely lowered, has fewer side effects
ESMOLOL
 β1- SELECTIVE BLOCKER
 RAPIDLY METABOLISED BY RBC
ESTERASES
 INDICATIONS: INTRA & POST
OP
HYPERTENSION, HYPERTENSIV
E EMERGENCIES PARTICULARLY
WHEN HYPERTENSION IS ASSOCATED
WITH TACHYCARDIA
PRAZOSIN & OTHER α1
BLOCKERS
 SELECTIVE BLOCKAGE OF α1
RECEPTORS IN ARTERIOLES &
VENULES
 LESS REFLEX TACHYCARDIA THAN
WITH NON SELECTIVE α BLOCKERS EG
PHENTOLAMINE
 DLATION OF RESISTANCE &
CAPACITANCE VESSELS
 B.P more in UPRIGHT position
 More effective with β blockers & a diuretic
TAMSULOSIN
INDICATED IN
BENIGN PROSTATIC
HYPERPLASIA &
HYPERTENSION
TOXICITY
 FIRST DOSE SYNCOPE:
PRECIPITOUS DROP IN STANDING B.P
AFTER 1ST DOSE 1ST DOSE
ADMINISTERRED AT BEDTIME; Occurs in
salt & vol. depleted pts
 DIZZINESS
 PALPITATIONS
 LASSITUDE
 HEADACHE
 +VE TEST FOR ANTI NUCLEAR
FACTOR BUT NO ASSOC. WITH R.A
NONSELECTIVE α BLOCKERS
 PHENTOLAMINE
+PROPRANOLOLCLONIDINE
WITHDRAWAL SYNDROME
 PHENTOLAMINE &
PHENOXYBENZAMINE:
PHEOCHROMOCYTOMA
VASODILATORS
ORAL
PARENTRAL
Ca BLOCKERS
HYDRALIZINE
 RELEASE OF N2O
 ARTERIOLAR DILATION
 TACHYPHYLAXIS TO ANTI-HTN
EFFECTS DEVELOPED RAPIDLY
 Low bioavailability ; first pass
metabolism by acetylation
TOXICITY
 Headache
 Nausea
 Palpitation
 Sweating
 Flushing
 Anorexia
 May provoke ANGINA or ISCHEMIC
ARRHYTHMIAS
 LUPUS-LIKE SYNDROME
arthralgia, myalgia, skin rashes, fever
 Peripheral neuropathy and drug
fever…RARE
MINOXIDIL
 SULPHATE DERIVATIVE OPENS
POTASSIUM CHANNELS IN SMOOTH
MUSCLESHYPERPOLARIZATION
ARTIRIOLAR DILATION
 INDICATIONS: HTN, HEART
FAILURE, BALDNESS(local action)
TOXICITY
 TACHYCARDIA, PALPITATIONS, ANG
INA, EDEMA WITHOUT β-
BLOCKER & DIURETIC
 HEADACHE, SWEATING, HYPERTRIC
HOSIS…RELATIVELY COMMON
SODIUM NITROPRUSSIDE
 INDICATIONS; HYPERTENSIVE
EMERGENCIES & HEART FAILURE
 MOA: ACTIVATION OF GUANYLYL
CYCLASE( VIA N2O OR DIRECT) INC.
INTRA CELLULAR cGMP RELAXES
VASCULAR SMOOTH MUSCLE
ARTERIAL & VENODILATION
 In pts with heart failure & low cardiac
output..output inc owing to afterload
reduction
DIAZOXIDE
 EFFECTIVE & LONG ACTING
 ARTERIOLAR DIATOR
 RAPID FALL IN SYSTEMIC
VASCULAR RESISTANCE
 OPENING OF POTASSIUM
CHANNELS
 HYPOTENSION ACHIEVED WITH
SMALLER DOSES IN CHRONIC
RENAL FAILURE
 Hypoglycemia secondary to
insulinoma
TOXICITY
CAN PROVOKE
 ANGINA
 ECG EVIDENCE OF ISCHEMIA
 CARDIAC FAILURE,
In pts with ischemic heart disease
 HYPERGLYCEMIA , particularly in pts
with RENAL INSUFFISIENCY
FENDOLOPAM
 PERIPHERAL ARTERIOLAR DILATOR
 HYPERTENSIVE EMERGENCIES &
POST-OPERATIVE HYPERTENSION
 AGONIST OF D1 RECEPTORS:
PERIPHERAL ARTERIAL DILATION &
NATRIURESIS.
 Metabolized by conjugation
TOXICITY
 REFLEX TACHYCARDIA
 HEADACHE
 FLUSHING
 INCREASES INTRAOCULAR
PRESSURE…CONTRAINDIC
ATED IN GLAUCOMA

Anti Hypertensives- pharmacology

  • 2.
  • 3.
    CENTRALLT ACTING SYMPATHOPLEGICS  MOA REDUCESYMPATHETIC OUTFLOW FROM VASOMOTOR CENTER BUT RETAIN OR EVEN INC SENSITIVITY TO BARORECEPTOR CONTROL Actions less dependent on posture
  • 4.
    METHLY DOPA  αMETHYLDOPAMINE  α METHYLNOREPINEPHERINE  ACT ON CENTRAL α ADRENOCEPTORS
  • 5.
    ACTIONS  REDUCE PERIPHERAL VASCULARRRESISTANCE  VARIABLE RED IN CARDIAC OUTPUT AND HEART RATE  DOA: 12-24HR
  • 6.
    TOXICITY  Postural hypotensionin vol. depleted pts  Sedation------at onset  LONG TERM USE-----persistent mental lassitude, impaired mental conc., nightmares, mental depression, extra- pyramidal signs  LACTATION—men & women.. Inhib of dopaminergic mech. in hypothalamus  POSITIVE COOMBS TEST---hemolytic anemia , hepatitis & drug fever  Discont.-----PROMPT REVERS OF ABNORMALITIES
  • 7.
    DRUG INTERACTIONS  NSAIDS SYSTEMIC CORTICOSTEROIDS
  • 8.
    CLONIDINE  α ADRENOCEPTORSIN MEDULLA OF BRAIN---Sensitizes vasomotor centers to Inhib by baroreflexes  RED. SYMPATHETIC AND INC. PARASYMPATHETIC TONE  Nonadrenoceptor site----IMIDAZOLE RECEPTOR
  • 9.
    ACTIONS  I/V---BRIEF INCIN BLOOD PRESSURE( PARTIAL α AGONIST) followed by MORE PROLONGED HYPOTENTION  DEC. CARDIAC RATE AND C.O  RELAXATION OF CAPACITANCE VESSELS---DEC IN PVR
  • 10.
    TOXICITY  SEDATION  DRYMOUTH  MENTAL DEPRESSION----WITHDRAW  WITHDRAWAL AFTER PROTRACTED USE: LIFE THREATENING HYPOTENSIVE CRISIS  Nervousness, tachycardia, headache & sweating---omitting 1 or 2 doses of drug
  • 11.
    DRUG INTERACTIONS  TCAMAY BLOCK THE ANTI HYPOTENSIVE EFFECT  NSAIDS MAY ENHANCE THE ANTIPOTENSIVE EFFECT
  • 12.
  • 13.
    GANGLION BLOCKING AGENTS  MOA COMPETITIVELY BLOCK NICOTINIC CHOLINOCEPTORS ON POST GANGLIONIC NEURONS IN BOTH SYMPATHETIC & PARASYMPATHETIC OUTFLOW  MAY DIRECTLY BLOCK NICOTINIC Ach channel
  • 14.
    TO NAME AFEW.. HEXAMETHONIUM MECAMYALINE TRIMETHAPHAN
  • 15.
    ADVERSE EFFECTS  SYMPATHOPLEGIA:excessive orthostatic hypotension & sexual dysfunction  PARASYMPATHOPLEGIA: constipation, blurred vision, precipitation of glaucoma, dry mouth, urinary retention
  • 16.
    ADRENERGIC NEURON BLOCKING AGENTS MOA PREVENT NORMAL PHYSIOLOGICAL RELEASE OF NOREPINEPHRINE FROM POST GANGLIONIC SYMPATHETIC NEURONS
  • 17.
    GUANITHIDINE  MOA---transported acrosssymp nerve ending by NET, conc. In vesicles, NE replaced….gradual depletion of NE
  • 18.
    TOXICITY  SYMPTOMATIC POSTURAL HYPOTENTIONOR AFTER EXERCISE  DIARREHA  DELAYED OR RETROGRADE EJACULATION
  • 19.
    CONTRA-INDICATIONS  SYMPATHOMIMETIC AGENTS—cause HYPERTENSION CAN PRODUCE HYPERTENSIVE CRISIS BY RELEASING CHATECHOLAMINES IN PTS WITH PHEOCHROMOCYTOMA  TCA ATTENUATE ANTIHYPERTENSIVE EFFECT--- SEVERE HYPERTENSION
  • 20.
    THESE BLOCK NEURONAL UPTAKEOR DISPLACE AMINES FROM NERVE TERMINALS  COCAINE  AMPHETAMINE  TCA  PHENOTHIAZINES  PHENOXYBENZAMINE
  • 21.
    RESERPINE  MOA  Blocksthe ability of aminergic transmitter vesicles to take up and store biological amines----interfere VMAT  -> DEPLETION OF NE, DOPAMINE & SEROTININ BOTH IN CENTRAL AND PERIPHERAL NERVOUS SYSTEM  CROMAFFIN GRANULES OF AD. MEDULLA ARE ALSO DEPLETED
  • 22.
    TOXICITY  LOW DOSES—LITTLEPOSTURAL HYPOTENSION  HIGH DOSES– SEDATION, LASSITUDE, NIGHTMARE S, SEVERE MENTAL DEPRESSION— occasionally with low doses too  EXTRAPYRAMIDAL EFFECTS due to low dopamine in CS.  GIT MILD DIARREHA, GIT CRAMPS, INCREASED GASTRIC ACID SECRETION  CONTRAINDICATED WITH H/O PEPTIC ULCER
  • 23.
  • 24.
    PROPRANOLOL  MOA  NONSELECTIVEβ- BLOCKADE  PRIMARILY DECREASE IN CARDIAC OUTPUT  INHIBITS STIMULATION OF RENIN PRODUCTION BY CATECHOLAMINES( β1)  ACTS ON PERIPHERAL PRESYNAPTIC β- ADRENOCEPTORS TO REDUCE SYMPATHETIC VASOCONSTRICTIVE ACTIVITY  IN MILD TO MODERATE HYPERTENSION SIGNIFICANT REDUCTION IB B.P WITHOUT PROMINENT POSTURAL HYPOTENSION
  • 25.
    TOXICITY  BRADYCHARDIA  WORSONEDASTHAMA  FATIGUE  VIVID DREAMS  COLD HANDS  DISCONTINUATION AFTER PROLONGED REGULAR USE WITHDRAWAL SYNDROME: nervousness, tachycardia, increased intensity of angina, increased B.P
  • 26.
    OTHERS  METOPROLOL &ATENOLOL  GREATER SELECTIVITY TO β1- ADRENOCEPTERS  INDICATIONS: HYPERTENSION, ARRYTHMIAS, ANGIN A, EARLY MANAGEMENT OF MI  Metoprolol thyrotoxicosis & migraine prophylaxis
  • 27.
     NADOLOL &CARTEOLOL: NONSELECTIVE β - RECPTOR ANTAGONISTS, REDUCED DOSES IN RENAL DISEASE  BETAXOLOL & BISOPROLOL:β1 BLOCKER
  • 28.
    PINDOLOL, ACEBUTOLOL, P ENBUTOLOL PARTIAL AGONISTS: β- BLOCKERS WITH SOME INTRINSIC SYMPATHOMIMETIC ACTIVITY  REDUCE VASCULAR RESISTANCE  REDUCE CARDIAC OUTPUT OR H.R LESS THAN OTHERS due to agonist activity beneficial in cases of bradyarrhythmias or PVD
  • 29.
    LABETOLO, CARVEDILOL, NE BIVOLOL β- BLOCKING AND VASODILATING ACTIVITY  LABETOLOL: 4 ISOMERS; 3:1 RATIO OF β:α BLOCKADE REDUCED SYSTEMIC VASCULAR RESISTANCE(α- BLOCKADE), COMBINED ACTIVITY PHEOCROMOCYTOMA & HYPERTENSIVE EMERGENCIES
  • 30.
    CONT..  CARVEDILOL: HEARTFAILURE AND HYPERTENSION  NEBIVOLOL:  D- ISOMER: β-1 SELECTIVE  L-ISOMER: NITRIC OXIDE SYNTHASE INDUCER PVR is acutely lowered, has fewer side effects
  • 31.
    ESMOLOL  β1- SELECTIVEBLOCKER  RAPIDLY METABOLISED BY RBC ESTERASES  INDICATIONS: INTRA & POST OP HYPERTENSION, HYPERTENSIV E EMERGENCIES PARTICULARLY WHEN HYPERTENSION IS ASSOCATED WITH TACHYCARDIA
  • 32.
    PRAZOSIN & OTHERα1 BLOCKERS  SELECTIVE BLOCKAGE OF α1 RECEPTORS IN ARTERIOLES & VENULES  LESS REFLEX TACHYCARDIA THAN WITH NON SELECTIVE α BLOCKERS EG PHENTOLAMINE  DLATION OF RESISTANCE & CAPACITANCE VESSELS  B.P more in UPRIGHT position  More effective with β blockers & a diuretic
  • 33.
  • 34.
    TOXICITY  FIRST DOSESYNCOPE: PRECIPITOUS DROP IN STANDING B.P AFTER 1ST DOSE 1ST DOSE ADMINISTERRED AT BEDTIME; Occurs in salt & vol. depleted pts  DIZZINESS  PALPITATIONS  LASSITUDE  HEADACHE  +VE TEST FOR ANTI NUCLEAR FACTOR BUT NO ASSOC. WITH R.A
  • 35.
    NONSELECTIVE α BLOCKERS PHENTOLAMINE +PROPRANOLOLCLONIDINE WITHDRAWAL SYNDROME  PHENTOLAMINE & PHENOXYBENZAMINE: PHEOCHROMOCYTOMA
  • 36.
  • 37.
    HYDRALIZINE  RELEASE OFN2O  ARTERIOLAR DILATION  TACHYPHYLAXIS TO ANTI-HTN EFFECTS DEVELOPED RAPIDLY  Low bioavailability ; first pass metabolism by acetylation
  • 38.
    TOXICITY  Headache  Nausea Palpitation  Sweating  Flushing  Anorexia  May provoke ANGINA or ISCHEMIC ARRHYTHMIAS  LUPUS-LIKE SYNDROME arthralgia, myalgia, skin rashes, fever  Peripheral neuropathy and drug fever…RARE
  • 39.
    MINOXIDIL  SULPHATE DERIVATIVEOPENS POTASSIUM CHANNELS IN SMOOTH MUSCLESHYPERPOLARIZATION ARTIRIOLAR DILATION  INDICATIONS: HTN, HEART FAILURE, BALDNESS(local action)
  • 40.
    TOXICITY  TACHYCARDIA, PALPITATIONS,ANG INA, EDEMA WITHOUT β- BLOCKER & DIURETIC  HEADACHE, SWEATING, HYPERTRIC HOSIS…RELATIVELY COMMON
  • 41.
    SODIUM NITROPRUSSIDE  INDICATIONS;HYPERTENSIVE EMERGENCIES & HEART FAILURE  MOA: ACTIVATION OF GUANYLYL CYCLASE( VIA N2O OR DIRECT) INC. INTRA CELLULAR cGMP RELAXES VASCULAR SMOOTH MUSCLE ARTERIAL & VENODILATION  In pts with heart failure & low cardiac output..output inc owing to afterload reduction
  • 42.
    DIAZOXIDE  EFFECTIVE &LONG ACTING  ARTERIOLAR DIATOR  RAPID FALL IN SYSTEMIC VASCULAR RESISTANCE  OPENING OF POTASSIUM CHANNELS  HYPOTENSION ACHIEVED WITH SMALLER DOSES IN CHRONIC RENAL FAILURE  Hypoglycemia secondary to insulinoma
  • 43.
    TOXICITY CAN PROVOKE  ANGINA ECG EVIDENCE OF ISCHEMIA  CARDIAC FAILURE, In pts with ischemic heart disease  HYPERGLYCEMIA , particularly in pts with RENAL INSUFFISIENCY
  • 44.
    FENDOLOPAM  PERIPHERAL ARTERIOLARDILATOR  HYPERTENSIVE EMERGENCIES & POST-OPERATIVE HYPERTENSION  AGONIST OF D1 RECEPTORS: PERIPHERAL ARTERIAL DILATION & NATRIURESIS.  Metabolized by conjugation
  • 45.
    TOXICITY  REFLEX TACHYCARDIA HEADACHE  FLUSHING  INCREASES INTRAOCULAR PRESSURE…CONTRAINDIC ATED IN GLAUCOMA

Editor's Notes

  • #26 UPREGULATION OR SUPER SENSITIVITY OF B RECEPTORS
  • #29 PVD; PERIPHERAL VASCULAR DISEASE